Physician profile
David R Blatt
NPI 1053411579
$482.72
in general payments reported to CMS, 2019-2025
8 companies · $62.50 in 2025
The $62.50 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $54.00 · 2021: $108 · 2022: $51.87 · 2023: $65.63 · 2024: $18.61 · 2025: $62.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $146.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $299.49 | 2019-2025 | Vivigen Mis Delivery System, Teligen, Viper |
| Cardiofocus, INC. | $51.87 | 2022 | |
| Integra Lifesciences Corporation | $38.28 | 2019 | |
| Zimmer Biomet Holdings, INC. | $32.20 | 2019 | |
| Misonix INC | $18.78 | 2020 | |
| Stryker Corporation | $18.61 | 2024 | Na, Universal Neuro 3 |
| Boston Scientific Corporation | $12.73 | 2020 | |
| Centinel Spine, LLC | $10.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Blatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.